Scientists from Plant & Food Research and Callaghan Innovation have discovered that a novel bioactive compound, sarmentosin, ...

Monoamine oxidase inhibitors (MAOIs) were the first medications approved for the treatment of depression symptoms and are also used to treat several other medical conditions, such as Parkinson's ...

Monoamine oxidase treats depression by preventing monoamine oxidase from removing those neurotransmitters. MAOIs keep dopamine, serotonin, and norepinephrine higher in the brain, which thereby ...

Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B ... selective and irreversible inhibitor of MAO-B that has ...

YOUR favourite spooky treat might be harbouring an unwanted trick, an expert has warned. Some ingredients lurking in your ...

Protect Your Health and Wellness Coffee is a beloved beverage for millions of people worldwide. Whether it is the morning ...

Am J Health Syst Pharm. 2006;63(10):915-928. Results of this study suggest that adjunctive rasagiline significantly reduces off time with efficacy similar to that observed by adding entacapone to ...

Many researchers and investors are excited by the announcement in April 2018 that ORY-2001 — an orally available selective inhibitor of lysine-specific demethylase (LSD1) and monoamine oxidase B ...

A pharmacist has issued a Halloween warning to anyone taking a range of medications as some sweets could, cause a dangerous ...

Delsym and Robitussin-DM contain the active ingredient dextromethorphan, a cough suppressant. In addition to dextromethorphan ...

Dopamine reuptake inhibition and binding inhibition of dopamine transporters were linked to antidepressant-related cardiovascular events.

serotonin–noradrenaline reuptake inhibitors, tricyclic antidepressants and monoamine oxidase inhibitors) operate slowly, targeting the serotonin, noradrenaline and dopamine-activated pathways ...